PRL and hyperprolactinemia: Recently, in a larger study (163 patients and 90 controls), Wang and colleagues found that hyperprolactinemia resulted in decreased total lumbar BMD in a group of male and female patients with schizophrenia (mean age of 36) who had been treated with PRL-raising APs for 12 months [18].